Hopfield Jessica

SEC CIK: 0001648715

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

EDIT Editas Medicine, Inc.Directoras of Jun 22, 2026
PODD Insulet CorpDirectoras of May 21, 2026
MRVI Maravai Lifesciences Holdings, Inc.Directoras of Jun 18, 2025
CELL Bruker Cellular Analysis, Inc.Directoras of Oct 3, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists Hopfield Jessica as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

PODD Insulet Corp

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 14, 2025 (view filing)	May 13	1 day	Hopfield JessicaDirector	SSale	−5.24K	$317.54	−$1.66M	−16.3%26.9K after
Sep 12, 2024 (view filing)	Sep 11	1 day	Hopfield JessicaDirector	SSale	−7.63K	$225.26	−$1.72M	−22.1%26.9K after

EDIT Editas Medicine, Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 14, 2024 (view filing)	May 13	1 day	Hopfield JessicaDirector	PPurchase	+45.0K	$5.64	+$253.8K	+198.2%67.7K after

CELL Bruker Cellular Analysis, Inc.